mdr-001
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started Jun 9, 2023 (NCT06778850)
Timeline
Indications
Studied for
Mechanism of action
GLP1R agonist
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07274137 | Phase 3 | Feb 28, 2026 | MindRank AI Ltd |
| NCT07110766 | Phase 1 | Aug 9, 2025 | MindRank AI Ltd |
| NCT06606483 | Phase 2 | Sep 23, 2024 | MindRank AI Ltd |
| NCT06778850 | Phase 1/Phase 2 (Phase 2) | Jun 9, 2023 | MindRank AI Ltd |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| MindRank AI Ltd | For profit | 4 | 4 | 3 | 2023 |
1 organizations
Page 1 / 1